Serum biomarkers of post-stroke depression
Ziliang Zhang, Jinbo Chen, Xiaowen Song, Yipeng Su
Abstract
Ziliang Zhang, Jinbo Chen, Xiaowen Song, Yipeng Su
Abstract
Post-stroke depression (PSD) is the most common psychiatric disorder after stroke, and mood disorders are the main manifestations. Clinical investigation shows that the prevalence of PSD is as high as 30%-50%. It seriously affects the lives and work of patients, and brings serious impact and heavy economic burden on individuals, families, and the entire society. The discovery of serum biomarkers of PSD has provided a new direction for its diagnosis and treatment. This article reviews the serum biomarker of PSD. Key words: Stroke; Depression; Biomarkers
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Post-stroke depression (PSD) is the most common psychiatric disorder after stroke, and mood disorders are the main manifestations. Clinical investigation shows that the prevalence of PSD is as high as 30%-50%. It seriously affects the lives and work of patients, and brings serious impact and heavy economic burden on individuals, families, and the entire society. The discovery of serum biomarkers of PSD has provided a new direction for its diagnosis and treatment. This article reviews the serum biomarker of PSD. Key words: Stroke; Depression; Biomarkers
Key concepts: Depression (economics), Post-stroke depression, Stroke (engine), Biomarker, Medicine, Mood, Psychiatry, Mood disorders